Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Rhodes Pharmaceuticals L.P.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Rhodes Pharmaceuticals L.P. with status Current. The shortage was first posted on Jul 14, 2023. Reported reason: Shortage of an active ingredient

Shortage details

Status
Current
Company
Rhodes Pharmaceuticals L.P.
Package NDC
42858-162-01
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)
Initial Posting
Jul 14, 2023

Reason

Shortage of an active ingredient

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.